Kimberly-Clark’s 2026Q2 Earnings Call: Growth Lag, Acquisition Delays, and EPS Decline Contradict Prior Guidance

<<>>

Date of Call: Aug 4, 2026

Financials Results

• Revenue: Q2 organic net sales were broadly flat; H1 organic net sales grew 1.2%.
• EPS: Adjusted EPS from continuing operations and adjusted EPS both increased 10.4% versus the prior year.
• Operating Margin: Adjusted operating profit increased 6.2% in Q2 and 4.9% in H1.

Guidance:

• Full-year organic growth now expected to be roughly 100 basis points below weighted average category growth for the year (down from prior expectation).
• Adjusted operating profit growth now expected to be mid-single digit on a constant currency basis (down from mid to high single digit).
• Adjusted EPS growth from continuing operations now expected high single-digit growth on a constant currency basis (down from double-digit).
• Adjusted EPS attributable to Kimberly-Clark now expected a low single-digit decline on a constant currency basis (down from in-line with 2025).
• Expect to deliver ~$2B adjusted free cash flow for the full year.
• Expect incremental second half gross input cost headwinds of ~$150M, largely offset by mitigating actions and tariff refunds.

Business Commentary:

Tenth Consecutive Quarter of Volume Plus Mix-Led Performance:

• Kimberly-Clark delivered its tenth consecutive quarter of volume plus mix-led performance, maintaining global weighted share and achieving industry-leading gross productivity.
• This performance was driven by the company's ability to out-innovate, out-market, and out-activate, despite a pressurized consumer environment and moderating category growth.

China Market Disruption:

• The company's results were significantly impacted by a 140 basis point headwind from a social media disruption in China, affecting the diaper business.
• False and misleading allegations regarding product quality emerged, impacting the company's Q2 results and expected recovery timeline.

Productivity and Cost Discipline:

• Kimberly-Clark achieved another strong quarter of productivity, with industry-leading gross productivity of 5%-6% of adjusted cost of goods sold.
• The focus on productivity is embedded in the company's culture, enabling investment in innovation while navigating cost volatility.

Strategic Transformation and Growth Initiatives:

• The company made significant progress in its strategic transformation, including the successful close of its partnership with Suzano and the unveiling of an alternative natural fiber innovation platform.
• These initiatives aim to reshape the future of the industry, reduce exposure to natural forest fiber cost volatility, and advance integration plans for the Kenvue acquisition.

North America Performance and Innovation:

• In North America, despite a 0.7% decline in organic growth, Kimberly-Clark continued to deliver superior value propositions with innovations like the next-generation Skin Essentials diaper.
• The company's science-backed innovation and marketing strategies strengthened its value propositions, despite a challenging consumer environment.

Sentiment Analysis:

Overall Tone: Neutral

• Results reflect 'a pressurized consumer environment, moderating category growth, and a few discrete but significant one-off impacts.' The company delivered strong operating performance and executed on strategic initiatives, but lowered its full-year outlook due to headwinds in China and a more cautious consumer environment. Management expressed confidence in the underlying business momentum and the durability of their growth engine.

Q&A:

• Question from Analyst: What was the impact of the China social media disruption on Q2 results and the full-year outlook?
  Response: The China social media disruption impacted Q2 results and is expected to temper the IPC segment's organic growth by 3-4 percentage points and hold back operating profit growth by 10-12 percentage points for the full year.

• Question from Analyst: What is the status of the Kenvue acquisition and expected synergies?
  Response: Regulatory process is on track for a Q4 close; integration planning is ahead of schedule with high confidence in achieving the $1.9B cost synergy target over three years.

Contradiction Point 1

Financial Forecast and Growth Outlook

Contradiction on the expected relationship between company growth and underlying category growth, shifting from targeting at or above category growth to being ~100 bps below.

Analyst (Question not specified) - Analyst (Question not specified)

2026Q2: Full-year organic growth is now ~100 bps below weighted category growth. - Nelson Urdaneta(CFO)

What are the key drivers and expected impacts on revenue and profit growth from the full-year outlook revision? - Christopher Carey (Wells Fargo Securities)

2025Q4: They aim for top-line growth at or above category growth. - Nelson Urdaneta(CFO)

Contradiction Point 2

Input Cost Headwind Management

Contradiction on confidence and specifics of mitigating significant input cost increases, shifting from a detailed, disciplined approach to a statement excluding acquisition benefits.

Analyst (Question not specified) - Analyst (Question not specified)

2026Q2: The outlook excludes any benefit from the acquisition closing before December 31, 2026. - Nelson Urdaneta(CFO)

What is the current status, expected timeline, and key synergy opportunities for the Kenvue acquisition? - Lauren Lieberman (Barclays Bank PLC)

2026Q1: The company has a track record of covering input costs and expanding margins... the company will take the necessary time to do this right before providing further specifics. - Nelson Urdaneta(CFO)

Contradiction Point 3

Kenvue Acquisition Regulatory Timeline

Contradiction on the expected closing timeline for the Kenvue acquisition, shifting from a second-half 2026 target to regulatory clearance now expected in Q4 2026.

Analyst (Question not specified) - Analyst (Question not specified)

2026Q2: Integration planning advancing and regulatory clearance expected in Q4 2026. - Mike Hsu(CEO)

What is the current status, expected timeline, and key synergy opportunities for the Kenvue acquisition? - Nik Modi (RBC Capital Markets)

2025Q4: The regulatory process is on track for a closing in the second half of 2026. - Michael Hsu(CEO)

Contradiction Point 4

Adjusted EPS Growth Outlook

Contradiction on the expected trajectory for adjusted EPS, shifting from muted growth to a low single-digit decline.

Analyst (Question not specified) - Analyst (Question not specified)

2026Q2: Adjusted EPS growth is lowered to high single digits... adjusted EPS attributable to Kimberly-Clark now expected to decline low single digits vs. 2025. - Nelson Urdaneta(CFO)

What were the key drivers behind the full-year outlook revision and their expected impact on revenue and profit growth? - Lauren Lieberman (Barclays)

2025Q3: EPS from continuing operations will see step-up growth... Adjusted EPS attributable to total KC will be muted in 2026 (half of discontinued ops income goes away) and in 2027 (all goes away), offset by underlying growth and dilution. - Nelson Urdaneta(CFO)

Contradiction Point 5

North America Organic Growth Outlook

Contradiction on the expected growth rate for North America in Q2 versus the full-year outlook, with a shift from expecting acceleration in the second half to no such acceleration mentioned.

Analyst (Question not specified) - Analyst (Question not specified)

2026Q2: North America organic growth is expected to be slightly below Q1 due to lapping a strong Q2 2025... and the ~70-80 bps headwind from the California DC fire. - Nelson Urdaneta(CFO)

What was the impact of the L.A. distribution center fire, and how is the company addressing the associated challenges? - Lauren Lieberman (Barclays Bank PLC)

2026Q1: In Q1, North America consumption was ahead of shipments by ~200 bps... For Q2, organic sales growth is expected to be slightly below Q1 due to lapping a strong Q2 2025... and the ~70-80 bps headwind from the California DC fire. However, organic growth is expected to accelerate in the second half as these noise elements are not projected to recur. - Nelson Urdaneta(CFO)

<<>>